Outcomes in hepatocellular carcinoma patients undergoing sorafenib treatment: toxicities, cellular oxidative stress, treatment adherence, and quality of life-Reference-Cited by-同舟云学术

Outcomes in hepatocellular carcinoma patients undergoing sorafenib treatment: toxicities, cellular oxidative stress, treatment adherence, and quality of life

Published:2020-06 Issue:5 Volume:31 Page:523-527
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Baldan Ferrari Graziele,Coelho França Quintanilha Júlia,Berlofa Visacri Marília,Oliveira Vaz Camila,Cursino Maria Aparecida,Sampaio Amaral Laís,Brito Bastos ,Pereira Taynna Tatiane,de Oliveira Guarnieri João Paulo,de Godoy Torso Nadine,Passos Lima Carmen Silvia,Moriel Patricia

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference37 articles.

1. Sorafenib: a review in hepatocellular carcinoma.;Keating;Target Oncol,2017

2. Liver cancer cell of origin, molecular class, and effects on patient prognosis.;Sia;Gastroenterology,2017

3. Advances in targeted therapies for hepatocellular carcinoma in the genomic era.;Llovet;Nat Rev Clin Oncol,2015

4. Sorafenib in advanced hepatocellular carcinoma.;Llovet;N Engl J Med,2008

5. The adverse effects of sorafenib in patients with advanced cancers.;Li;Basic Clin Pharmacol Toxicol,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Novel Combinatorial Regimen Using Sorafenib and Uttroside B, A US FDA-designated ‘Orphan Drug’, for the Treatment of Hepatocellular Carcinoma;Anti-Cancer Agents in Medicinal Chemistry;2024-08-09

2. Comprehensive analysis of ASB3 as a prognostic biomarker in hepatocellular carcinoma;Translational Oncology;2024-01

3. Sorafenib versus Lenvatinib Causes Stronger Oxidative Damage to Membrane Lipids in Noncancerous Tissues of the Thyroid, Liver, and Kidney: Effective Protection by Melatonin and Indole-3-Propionic Acid;Biomedicines;2022-11-11

4. Carbon Quantum Dots-Based Nanozyme from Coffee Induces Cancer Cell Ferroptosis to Activate Antitumor Immunity;ACS Nano;2022-05-27

5. GLUT1: a promising drug target for cancer treatment;Anti-Cancer Drugs;2021-04